{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T12:09:09Z","timestamp":1787400549481,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.nut.2019.110664","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T11:25:32Z","timestamp":1575026732000},"page":"110664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Could nutritional therapy take us further in our approaches to Fabry disease?"],"prefix":"10.1016","volume":"72","author":[{"given":"Francesco","family":"Francini-Pesenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verdiana","family":"Ravarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6498-6671","authenticated-orcid":false,"given":"Giovanni","family":"Bertoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Spinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo A.","family":"Cal\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2019.110664_bib0001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nut.2019.110664_bib0002","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease","volume":"146","author":"Clarke","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nut.2019.110664_bib0003","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nut.2019.110664_bib0004","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.semperi.2015.03.005","article-title":"Newborn screening for lysosomal storage disorders","volume":"39","author":"Matern","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.nut.2019.110664_bib0005","first-page":"88","article-title":"Fabry disease","volume":"1","author":"Thomas","year":"2014","journal-title":"Pediatr Endocrinol Rev. Suppl"},{"key":"10.1016\/j.nut.2019.110664_bib0006","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Takenaka","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2019.110664_bib0007","series-title":"Fabry disease: perspectives from 5 years of FOS","article-title":"Fabry disease in females: clinical characteristics and effects of enzyme replacement therapy","author":"Deegan","year":"2006"},{"key":"10.1016\/j.nut.2019.110664_bib0008","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","article-title":"Fabry disease: a review of current management strategies","volume":"103","author":"Mehta","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.nut.2019.110664_bib0009","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry's disease with the pharmacologic chaperone migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nut.2019.110664_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2012030316","article-title":"Agalsidase benefits renal histology in young patients with Fabry disease","volume":"24","author":"Tondel","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2019.110664_bib0011","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2215\/CJN.04340510","article-title":"Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry registry","volume":"5","author":"Wanner","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2019.110664_bib0012","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/ndt\/gfp528","article-title":"Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)","volume":"25","author":"Fogo","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nut.2019.110664_bib0013","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.2010.484","article-title":"Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease","volume":"79","author":"Najafian","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.nut.2019.110664_bib0014","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1750-1172-8-116","article-title":"Fibrosis: a key feature of Fabry disease with potential therapeutic implications","volume":"8","author":"Weidemann","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nut.2019.110664_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2369-15-72","article-title":"Fabry nephropathy: a review \u2013 how can we optimize the management of Fabry nephropathy?","volume":"15","author":"Waldek","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nut.2019.110664_bib0016","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bmj.39576.709711.80","article-title":"Nephrotic syndrome in adults","volume":"336","author":"Hull","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.nut.2019.110664_bib0017","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10157-014-1031-9","article-title":"Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy","volume":"19","author":"Kaku","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nut.2019.110664_bib0018","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MNH.0000000000000073","article-title":"Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease","volume":"23","author":"Humalda","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nut.2019.110664_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/nu10060732","article-title":"Dietary salt restriction in chronic kidney disease: a meta-analysis of randomized clinical trials","volume":"10","author":"Garofalo","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2019.110664_bib0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s40620-017-0435-5","article-title":"Diet and enteral nutrition in patients with chronic kidney disease not on dialysis: a review focusing on fat, fiber and protein intake","volume":"30","author":"Sabatino","year":"2017","journal-title":"J Nephrol"},{"key":"10.1016\/j.nut.2019.110664_bib0021","article-title":"Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.110664_bib0022","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2215\/CJN.01780213","article-title":"Mediterranean diet, kidney function, and mortality in men with CKD","volume":"8","author":"Huang","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2019.110664_bib0023","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.2215\/CJN.01080114","article-title":"The association between a Mediterranean-style diet and kidney function in the Northern Manhattan Study cohort","volume":"9","author":"Khatri","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2019.110664_bib0024","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/j.jrn.2013.08.004","article-title":"Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases","volume":"23","author":"Chauveau","year":"2013","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.nut.2019.110664_bib0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.23736\/S0031-0808.17.03302-X","article-title":"Phosphorus and other aspects of CKD-MBD in the conservative management of chronic kidney disease","volume":"59","author":"Shah","year":"2017","journal-title":"Panminerva Med"},{"key":"10.1016\/j.nut.2019.110664_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nut.2019.110664_bib0027","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MNH.0000000000000212","article-title":"The dual roles of obesity in chronic kidney disease: a review of the current literature","volume":"25","author":"Rhee","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nut.2019.110664_bib0028","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1651-2227.2006.tb02186.x","article-title":"Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey","volume":"95","author":"Ramaswami","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.nut.2019.110664_bib0029","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/1756283X16642936","article-title":"Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis","volume":"9","author":"Zar-Kessler","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.nut.2019.110664_bib0030","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cgh.2007.08.012","article-title":"Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy","volume":"5","author":"Hoffmann","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2019.110664_bib0031","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.nut.2019.110664_bib0032","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.nut.2019.110664_bib0033","series-title":"Fabry disease: perspectives from 5 years of FOS","article-title":"Gastrointestinal manifestations of Fabry disease","author":"Keshav","year":"2006"},{"key":"10.1016\/j.nut.2019.110664_bib0034","first-page":"8","article-title":"Chronic intestinal pseudo-obstruction. Did you search for lysosomal storage diseases?","volume":"11","author":"Politei","year":"2017","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.nut.2019.110664_bib0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cge.12673","article-title":"Gastrointestinal involvement in Fabry disease. So important, yet often neglected","volume":"89","author":"Politei","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.nut.2019.110664_bib0036","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","article-title":"Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry","volume":"64","author":"Hopkin","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.nut.2019.110664_bib0037","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.dld.2018.02.011","article-title":"Non-specific gastrointestinal features: could it be Fabry disease?","volume":"50","author":"Hilz","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.nut.2019.110664_bib0038","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13023-014-0169-6","article-title":"Agalsidase alfa in pediatric patients with Fabry disease: a 6.5-year open-label follow-up study","volume":"9","author":"Schiffmann","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nut.2019.110664_bib0039","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00042737-200410000-00020","article-title":"Effect of enzyme-replacement therapy on gastrointestinal symptoms in Fabry disease","volume":"16","author":"Hoffmann","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2019.110664_bib0040","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00006231-199809000-00009","article-title":"Gastrointestinal symptoms and delayed gastric emptying in Fabry's disease: response to metoclopramide","volume":"19","author":"Argoff","year":"1998","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nut.2019.110664_bib0041","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2377-11-61","article-title":"Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel","volume":"11","author":"Burlina","year":"2011","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nut.2019.110664_bib0042","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2015.10.007","article-title":"The management and treatment of children with Fabry disease: a United States-based perspective","volume":"117","author":"Hopkin","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nut.2019.110664_bib0043","doi-asserted-by":"crossref","first-page":"649","DOI":"10.5009\/gnl13437","article-title":"Association between diet and lifestyle habits and irritable bowel syndrome: a case\u2013control study","volume":"9","author":"Guo","year":"2015","journal-title":"Gut Liver"},{"key":"10.1016\/j.nut.2019.110664_bib0044","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.3748\/wjg.v23.i21.3771","article-title":"Diet in irritable bowel syndrome: what to recommend, not what to forbid to patients!","volume":"23","author":"Cozma-Petrut","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nut.2019.110664_bib0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2013.386","article-title":"Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI","volume":"109","author":"Murray","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nut.2019.110664_bib0046","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gutjnl-2017-313750","article-title":"The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS","volume":"66","author":"Staudacher","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.nut.2019.110664_bib0047","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders","volume":"130","author":"Tack","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2019.110664_bib0048","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1756283X09356590","article-title":"Peura DA Evaluation and management of dyspepsia","volume":"3","author":"Harmon","year":"2010","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.nut.2019.110664_bib0049","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","article-title":"Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide","volume":"109","author":"De Francesco","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nut.2019.110664_bib0050","first-page":"1","article-title":"Innate and adaptive immune response in Fabry disease","volume":"22","author":"Mauhin","year":"2015","journal-title":"J Inher Metab Dis Rep"},{"issue":"suppl 1","key":"10.1016\/j.nut.2019.110664_bib0051","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/s10545-009-1060-9","article-title":"Leukocyte perturbation associated with Fabry disease","volume":"32","author":"Rozenfeld","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nut.2019.110664_bib0052","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lfs.2018.08.067","article-title":"Oxidative stress \u2013 chronic kidney disease \u2013 cardiovascular disease: a vicious circle","volume":"210","author":"Ravarotto","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.nut.2019.110664_bib0053","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4161\/auto.6.5.11943","article-title":"Autophagosome maturation is impaired in Fabry disease","volume":"6","author":"Ch\u00e9vrier","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.nut.2019.110664_bib0054","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/15548627.2015.1071759","article-title":"Modulation of inflammation by autophagy: consequences for human disease","volume":"12","author":"Netea-Maier","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.nut.2019.110664_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40169-017-0154-5","article-title":"Autophagy and inflammation","volume":"6","author":"Qian","year":"2017","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.nut.2019.110664_bib0056","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nut.2019.110664_bib0057","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat Immunology"},{"key":"10.1016\/j.nut.2019.110664_bib0058","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1017\/S0007114515002093","article-title":"Low-grade inflammation, diet composition and health: current research evidence and its translation","volume":"114","author":"Minihane","year":"2015","journal-title":"Br J Nutr"},{"key":"10.1016\/j.nut.2019.110664_bib0059","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2015.03.014","article-title":"Omega 3 (n-3) fatty acids down-regulate nuclear factor-kappa B (NF-\u03baB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell disease","volume":"55","author":"Daak","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.nut.2019.110664_bib0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejphar.2015.11.001","article-title":"DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation","volume":"785","author":"Duvall","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nut.2019.110664_bib0061","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nut.2019.110664_bib0062","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.2013.520","article-title":"Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease","volume":"86","author":"Shu","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.nut.2019.110664_bib0063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204618","article-title":"Oxidative stress and the altered reaction to it in Fabry disease: a possible target for cardiovascular-renal remodelling?","volume":"13","author":"Ravarotto","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.110664_bib0064","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbadis.2011.11.001","article-title":"Globotriaosylceramide is correlated with oxidative stress and inflammation in fabry patients treated with enzyme replacement therapy","volume":"1822","author":"Biancini","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nut.2019.110664_bib0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/jcm7110409","article-title":"Oxidative stress and Cardiovascular-renal damage in Fabry disease: is there room for a pathophysiological involvement?","volume":"7","author":"Ravarotto","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.nut.2019.110664_bib0066","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/EBC20170055","article-title":"Dysregulation of autophagy as a common mechanism in lysosomal storage diseases","volume":"61","author":"Seranova","year":"2017","journal-title":"Essays Biochem"},{"key":"10.1016\/j.nut.2019.110664_bib0067","doi-asserted-by":"crossref","first-page":"e63506","DOI":"10.1371\/journal.pone.0063506","article-title":"Dysregulated autophagy contributes to podocyte damage in Fabry's disease","volume":"8","author":"Liebau","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2019.110664_bib0068","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S002966511000162X","article-title":"Flavonoids as anti-inflammatory agents","volume":"69","author":"Serafini","year":"2010","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.nut.2019.110664_bib0069","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jn\/138.4.753","article-title":"Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults","volume":"138","author":"Chun","year":"2008","journal-title":"J Nutr"},{"key":"10.1016\/j.nut.2019.110664_bib0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fphys.2018.00394","article-title":"Flavonoids in kidney health and disease","volume":"9","author":"Vargas","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.nut.2019.110664_bib0071","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2017.09.001","article-title":"Anti-inflammatory effects of flavonoids in neurodegenerative disorders","volume":"153","author":"Spagnuolo","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.nut.2019.110664_bib0072","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.clnu.2013.06.010","article-title":"Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients","volume":"33","author":"Calo","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2019.110664_bib0073","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.nut.2019.110664_bib0074","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cellimm.2012.05.011","article-title":"Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells","volume":"277","author":"Liu","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1016\/j.nut.2019.110664_bib0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/nu10010062","article-title":"Adherence to the Mediterranean diet and inflammatory markers","volume":"10","author":"Sureda","year":"2018","journal-title":"Nutrients"},{"issue":"suppl","key":"10.1016\/j.nut.2019.110664_bib0076","doi-asserted-by":"crossref","first-page":"500S","DOI":"10.1080\/07315724.2009.10718117","article-title":"The Okinawan diet: health implications of a low-calorie, nutrient-dense, antioxidant-rich dietary pattern low in glycemic load","volume":"28","author":"Willcox","year":"2009","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.nut.2019.110664_bib0077","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/0884533617700353","article-title":"Anti-inflammatory diet in clinical practice: a review","volume":"32","author":"Ricker","year":"2017","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.nut.2019.110664_bib0078","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.arr.2018.08.004","article-title":"The effect of fasting or calorie restriction on autophagy induction: a review of the literature","volume":"47","author":"Bagherniya","year":"2018","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.nut.2019.110664_bib0079","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbcan.2018.03.004","article-title":"Protein restriction and cancer","volume":"1869","author":"Yin","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.nut.2019.110664_bib0080","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/nu10050544","article-title":"A low-protein diet for diabetic kidney disease: its effect and molecular mechanism, an approach from animal studies","volume":"10","author":"Kitada","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2019.110664_bib0081","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/auto.2984","article-title":"Autophagy and lysosomes in Pompe disease","volume":"2","author":"Fukuda","year":"2006","journal-title":"Autophagy"},{"key":"10.1016\/j.nut.2019.110664_bib0082","doi-asserted-by":"crossref","first-page":"353","DOI":"10.15252\/emmm.201606547","article-title":"Modulation of mTOR signaling as a strategy for the treatment of Pompe disease","volume":"9","author":"Lim","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.nut.2019.110664_bib0083","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.nut.2019.110664_bib0084","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/15548627.2016.1151597","article-title":"Emerging role of mammalian autophagy in ketogenesis to overcome starvation","volume":"12","author":"Takagi","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.nut.2019.110664_bib0085","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","article-title":"Mitochondria: in sickness and in health","volume":"148","author":"Nunnari","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nut.2019.110664_bib0086","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/eci.12591","article-title":"Ketogenic diets: from cancer to mitochondrial diseases and beyond","volume":"46","author":"Branco","year":"2016","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.nut.2019.110664_bib0087","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/brainsci8080148","article-title":"The expanding role of ketogenic diets in adult neurological disorders","volume":"8","author":"McDonald","year":"2018","journal-title":"Brain Sci"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900719302473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900719302473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:10:13Z","timestamp":1760271013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900719302473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":87,"alternative-id":["S0899900719302473"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2019.110664","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could nutritional therapy take us further in our approaches to Fabry disease?","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2019.110664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110664"}}